| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 11/12/2009 | US20090281114 Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction |
| 11/12/2009 | US20090281108 Prenatal dietary supplement |
| 11/12/2009 | US20090281097 Nitrogen-containing heterocyclic compound |
| 11/12/2009 | US20090281087 Compounds II |
| 11/12/2009 | US20090281075 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
| 11/12/2009 | US20090281060 Heterocyclic derivatives as gpcr receptor agonists |
| 11/12/2009 | US20090281057 Botanically Derived Composition and a Process Thereof |
| 11/12/2009 | US20090281051 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient |
| 11/12/2009 | US20090281040 Methods For Treating Endoplasmic Reticulum (ER) Stress Disorders |
| 11/12/2009 | US20090281032 Modified CCK peptides |
| 11/12/2009 | US20090280987 Method For Solubilising, Dispersing and Stabilising of Substances, Products Manufactured According To The Method As Well As The Use Thereof |
| 11/12/2009 | US20090280151 Fabric with active principles and relevant recharging method of the active principles |
| 11/12/2009 | US20090280096 Pancreatic endocrine progenitor cells derived from pluripotent stem cells |
| 11/12/2009 | CA2725209A1 Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction |
| 11/12/2009 | CA2723820A1 Pancreatic endocrine progenitor cells derived from pluripotent stem cells |
| 11/12/2009 | CA2723550A1 Alpha-mercapto-amides |
| 11/12/2009 | CA2723440A1 Sulfobetaines for therapy |
| 11/12/2009 | CA2723429A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators |
| 11/12/2009 | CA2723131A1 Compositions comprising galactomannan and a process thereof |
| 11/12/2009 | CA2721815A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 11/12/2009 | CA2719288A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors |
| 11/11/2009 | EP2116547A1 Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands |
| 11/11/2009 | EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 11/11/2009 | EP2116535A1 Glucokinase-activating substance |
| 11/11/2009 | EP2116533A1 Glucokinase activator |
| 11/11/2009 | EP2116523A1 Rexinoid compound having alkoxy group |
| 11/11/2009 | EP2116264A1 Preparation for transnasal application |
| 11/11/2009 | EP2116244A1 Method of treating atherosclerosis, dyslipidemias and related conditions |
| 11/11/2009 | EP2116238A1 Amino acid composition |
| 11/11/2009 | EP2116235A1 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 11/11/2009 | EP2114971A1 Fused aromatic ptp-1b inhibitors |
| 11/11/2009 | EP2114944A2 Tetrahydrobiopterin prodrugs |
| 11/11/2009 | EP2114937A1 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals |
| 11/11/2009 | EP2114900A1 Thiopyrimidine-based compounds and uses thereof |
| 11/11/2009 | EP2114892A1 Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments |
| 11/11/2009 | EP2114879A1 Ppar active compounds |
| 11/11/2009 | EP2114437A2 Modified corticotropin releasing factor peptides and uses thereof |
| 11/11/2009 | EP2114430A1 Trpv1+ sensory neurons control of beta-cell stress and islet inflammation in diabetes |
| 11/11/2009 | EP2114424A1 Solid betalain compositions and methods |
| 11/11/2009 | EP2114417A1 New use of nitrites and nitrates and compositions containing these |
| 11/11/2009 | EP2114414A1 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders |
| 11/11/2009 | EP2114404A1 Pharmaceutical compound and composition |
| 11/11/2009 | EP2114386A1 Pharmaceutical composition for treatment of diabetic complications |
| 11/11/2009 | EP2114384A2 Compositions and methods for enhancing transmucosal delivery |
| 11/11/2009 | EP1960401B1 Tricyclic amide derivatives useful for treating obesity |
| 11/11/2009 | EP1856065B1 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
| 11/11/2009 | EP1841770B1 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 11/11/2009 | EP1669462B1 Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
| 11/11/2009 | EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 11/11/2009 | EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone |
| 11/11/2009 | EP1372634B1 Use of fumaric acid amides |
| 11/11/2009 | EP1196163B1 Pharmaceutical compositions for the treatment of insulin resistance |
| 11/11/2009 | CN101578284A Agent for improving insulin resistance |
| 11/11/2009 | CN101575326A Method for extracting tea polyphenol from glede tea |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574517A Adjuvant-free immunity regulating agent for preventing and treating type 1 diabetes |
| 11/11/2009 | CN101574476A Medicinal material composition used for lowering lipid and protecting liver auxiliarily |
| 11/11/2009 | CN101574471A Medicament for treating diabetes and preparation method thereof |
| 11/11/2009 | CN101574462A Drug composition for reducing blood sugar and blood fat and curing diabetes |
| 11/11/2009 | CN101574461A Drug composition for reducing blood sugar and blood fat and curing diabetes |
| 11/11/2009 | CN101574447A Anti-fat lipid-lowering and blood-pressure-lowing hawthorn wine and preparation method thereof |
| 11/11/2009 | CN101574438A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574437A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574436A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574435A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574434A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574433A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574424A Application of medicine combination in preparing medicament with function of protecting pancreatic island |
| 11/11/2009 | CN101574423A Application of medicine combination in preparing medicament for reducing insulin resistance |
| 11/11/2009 | CN101574418A Traditional Chinese medicine tea for treating high blood pressure, hyperlipoidemia and hyperglycosemia |
| 11/11/2009 | CN101574406A Drug composition for reducing blood fat |
| 11/11/2009 | CN101574405A Drug composition for reducing blood fat |
| 11/11/2009 | CN101574404A Drug composition for reducing blood fat |
| 11/11/2009 | CN101574403A Drug composition for reducing blood fat |
| 11/11/2009 | CN101574402A Drug composition for reducing blood fat |
| 11/11/2009 | CN101574401A Drug composition for reducing blood fat |
| 11/11/2009 | CN101574396A Compound preparation of fructus schisandrae and evening primrose CO* supercritical extract and preparation process |
| 11/11/2009 | CN101574392A Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid |
| 11/11/2009 | CN101574391A Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside |
| 11/11/2009 | CN101574383A Prevention and treatment of diseases induced by microcirculation disturbance with panax notoginoside |
| 11/11/2009 | CN101574380A Flavone acetylsalicylate solid dispersion and preparation method thereof |
| 11/11/2009 | CN101574371A Drug composition for reducing blood sugar and blood fat |
| 11/11/2009 | CN101574370A Drug composition for reducing blood sugar and blood fat |
| 11/11/2009 | CN101574369A Drug composition for reducing blood sugar and blood fat |
| 11/11/2009 | CN101574368A Drug composition for reducing blood sugar and blood fat |
| 11/11/2009 | CN101574367A Drug composition for reducing blood sugar and blood fat |
| 11/11/2009 | CN101574366A Drug composition for reducing blood sugar and blood fat |
| 11/11/2009 | CN101574365A Drug composition for reducing blood sugar and blood fat |
| 11/11/2009 | CN101574360A Application of epimedin in preparing medicines for treating diseases where estrogen needs supplementing |
| 11/11/2009 | CN101574348A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing |
| 11/11/2009 | CN101574347A Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing |
| 11/11/2009 | CN101574345A Compound simvastatin niacin sustained release tablet and preparation method thereof |
| 11/11/2009 | CN101574344A Niacin and statin medicinal composition and preparation method thereof |
| 11/11/2009 | CN101574343A Medicament composition for treating sugar diabetes |
| 11/11/2009 | CN101574335A Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven carbon fatty acid |
| 11/11/2009 | CN101574334A Method for preparing calcium gluconate preparation |
| 11/11/2009 | CN101574323A Migltol microcapsule tablet and preparation method thereof |
| 11/11/2009 | CN101574144A Application of 3'-deoxyadenosine in reducing weight, enhancing insulin sensitivity and improving lipid metabolism |
| 11/11/2009 | CN100558899C Growth hormone fusion protein |
| 11/11/2009 | CN100558717C Novel medicine |